AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
Vaccine therapy of B cell malignancies: Different strategies for a novel approach
Authors: Liso, A Benedetti, R Flenghi, L Falini, B
Citation: A. Liso et al., Vaccine therapy of B cell malignancies: Different strategies for a novel approach, LEUK LYMPH, 42(5), 2001, pp. 881-889
Diffuse large B-cell lymphoma with primary retroperitoneal presentation: Clinico-pathologic study of nine cases
Authors: Pileri, SA Zinzani, PL Ascani, S Orcioni, GF Gamberi, B Piccioli, M Sabattini, E Poggi, S Piccaluga, PP Falini, B
Citation: Sa. Pileri et al., Diffuse large B-cell lymphoma with primary retroperitoneal presentation: Clinico-pathologic study of nine cases, ANN ONCOL, 12(10), 2001, pp. 1445-1453
Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry
Authors: Natkunam, Y Warnke, RA Montgomery, K Falini, B van de Rijn, M
Citation: Y. Natkunam et al., Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry, MOD PATHOL, 14(7), 2001, pp. 686-694
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical studyof 89 patients treated with MACOP-B chemotherapy and radiation therapy
Authors: Zinzani, PL Martelli, M De Renzo, A Zaccaria, A Pavone, E Bocchia, M Falini, B Gobbi, M Gherlinzoni, F Bendandi, M Stefoni, V Tani, M Tura, S
Citation: Pl. Zinzani et al., Primary mediastinal large B-cell lymphoma with sclerosis: a clinical studyof 89 patients treated with MACOP-B chemotherapy and radiation therapy, HAEMATOLOG, 86(2), 2001, pp. 187-191
Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma - Evidence for derivation from germinal center B cells?
Authors: de Leval, L Ferry, JA Falini, B Shipp, M Harris, NL
Citation: L. De Leval et al., Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma - Evidence for derivation from germinal center B cells?, AM J SURG P, 25(10), 2001, pp. 1277-1282
Anaplastic large cell lymphoma: Pathological, molecular and clinical features
Authors: Falini, B
Citation: B. Falini, Anaplastic large cell lymphoma: Pathological, molecular and clinical features, BR J HAEM, 114(4), 2001, pp. 741-760
Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulintranscription
Authors: Stein, H Marafioti, T Foss, HD Laumen, H Hummel, M Anagnostopoulos, I Wirth, T Demel, G Falini, B
Citation: H. Stein et al., Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulintranscription, BLOOD, 97(2), 2001, pp. 496-501
Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy
Authors: Pileri, SA Facchetti, F Ascani, S Sabattini, E Poggi, S Piccioli, M Rondelli, D Vergoni, F Zinzani, PL Piccaluga, PP Falini, B Isaacson, PG
Citation: Sa. Pileri et al., Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy, AM J PATH, 159(3), 2001, pp. 915-924
Primary eyelid plasmacytoma
Authors: Olivieri, L Di Ianni, M Giansanti, M Falini, B Tabilio, A
Citation: L. Olivieri et al., Primary eyelid plasmacytoma, MED ONCOL, 17(1), 2000, pp. 74-75
Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3
Authors: Villamor, N Costa, D Aymerich, M Esteve, J Carrio, A Rozman, M Aguilar, JL Falini, B Montserrat, E Campo, E Colomer, D
Citation: N. Villamor et al., Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3, AM J CLIN P, 114(5), 2000, pp. 786-792
Immunophenotypic and genotypic markers of follicular center cell neoplasiain diffuse large B-cell lymphomas
Authors: King, BE Chen, C Locker, J Kant, J Okuyama, K Falini, B Swerdlow, SH
Citation: Be. King et al., Immunophenotypic and genotypic markers of follicular center cell neoplasiain diffuse large B-cell lymphomas, MOD PATHOL, 13(11), 2000, pp. 1219-1231
Anaplastic lymphoma kinase expression as a marker of malignancy Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction
Authors: Piccaluga, PP Ascani, S Orcioni, GF Piccioli, M Pileri, A Falini, B Pileri, SA
Citation: Pp. Piccaluga et al., Anaplastic lymphoma kinase expression as a marker of malignancy Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction, HAEMATOLOG, 85(9), 2000, pp. 978-981
The pathologist's view point. Part I - indolent lymphomas
Authors: Pileri, SA Ascani, S Sabatini, E Fraternali-Orcioni, G Poggi, S Piccioli, M Piccaluga, PP Gamberi, B Zinzani, PL Leoncini, L Falini, B
Citation: Sa. Pileri et al., The pathologist's view point. Part I - indolent lymphomas, HAEMATOLOG, 85(12), 2000, pp. 1291-1307
The pathologist's view point. Part II - aggressive lymphomas
Authors: Pileri, SA Ascani, S Sabattini, E Fraternali-Orcioni, G Poggi, S Piccoli, M Piccaluga, PP Gamberi, B Zinzani, PL Leoncini, L Falini, B
Citation: Sa. Pileri et al., The pathologist's view point. Part II - aggressive lymphomas, HAEMATOLOG, 85(12), 2000, pp. 1308-1321
CD30(+) T cells in rheumatoid synovitis: Mechanisms of recruitment and functional role
Authors: Gerli, R Pitzalis, C Bistoni, O Falini, B Costantini, V Russano, A Lunardi, C
Citation: R. Gerli et al., CD30(+) T cells in rheumatoid synovitis: Mechanisms of recruitment and functional role, J IMMUNOL, 164(8), 2000, pp. 4399-4407
ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occursbefore dissemination
Authors: ten Berge, RL Oudejans, JJ Ossenkoppele, GJ Pulford, K Willemze, R Falini, B Chott, A Meijer, CJLM
Citation: Rl. Ten Berge et al., ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occursbefore dissemination, J CLIN PATH, 53(6), 2000, pp. 445-450
Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity
Authors: Leoncini, L Lazzi, S Scano, D Mura, A Onida, A Massarelli, G Tosi, P Barbini, P Cevenini, G Massai, MR Pileri, S Falini, B Giordano, A Kraft, R Laissue, JA Cottier, H
Citation: L. Leoncini et al., Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity, INT J CANC, 86(6), 2000, pp. 777-781
Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects
Authors: Boncristiano, M Majolini, MB D'Elios, MM Pacini, S Valensin, S Ulivieri, C Amedei, A Falini, B Del Prete, G Telford, JL Baldari, CT
Citation: M. Boncristiano et al., Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects, EUR J IMMUN, 30(9), 2000, pp. 2632-2638
A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma
Authors: Trinei, M Lanfrancone, L Campo, E Pulford, K Mason, DY Pelicci, PG Falini, B
Citation: M. Trinei et al., A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma, CANCER RES, 60(4), 2000, pp. 793-798
Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma
Authors: Pulford, K Falini, B Banham, AH Codrington, D Roberton, H Hatton, C Mason, DY
Citation: K. Pulford et al., Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma, BLOOD, 96(4), 2000, pp. 1605-1607
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
Authors: Stein, H Foss, HD Durkop, H Marafioti, T Delsol, G Pulford, K Pileri, S Falini, B
Citation: H. Stein et al., CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features, BLOOD, 96(12), 2000, pp. 3681-3695
A monoclonal antibody (MUM1p) detects expression of the MUM 1/IRF4 proteinin a subset of germinal center B cells, plasma cells, and activated T cells
Authors: Falini, B Fizzotti, M Pucciarini, A Bigerna, B Marafioti, T Gambacorta, M Pacini, R Alunni, C Natali-Tanci, L Ugolini, B Sebastiani, C Cattoretti, G Pileri, S Dalla-Favera, R Stein, H
Citation: B. Falini et al., A monoclonal antibody (MUM1p) detects expression of the MUM 1/IRF4 proteinin a subset of germinal center B cells, plasma cells, and activated T cells, BLOOD, 95(6), 2000, pp. 2084-2092
Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia - A phase III, randomized, multicenter study
Authors: Mandelli, F Lauria, F Majolino, I Meloni, G Santini, G Foa, R Castoldi, G Corradini, P Falini, B Pileri, S Liso, V
Citation: F. Mandelli et al., Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia - A phase III, randomized, multicenter study, HEM CELL TH, 41(3), 1999, pp. 117-125
T-cell prolymphocytic leukaemia: Does the expression of CD8+phenotype justify the identification of a new subtype? Description of two cases and review of the literature
Authors: Ascani, S Leoni, P Orcioni, GF Bearzi, I Piccioli, M Materazzi, M Zinzani, PL Gherlinzoni, F Falini, B Pileri, SA
Citation: S. Ascani et al., T-cell prolymphocytic leukaemia: Does the expression of CD8+phenotype justify the identification of a new subtype? Description of two cases and review of the literature, ANN ONCOL, 10(6), 1999, pp. 649-653
Soluble CD30 in primary Sjogren's syndrome
Authors: Gerli, R Caligaris-Cappio, F Bistoni, O Bertero, MT Giacomelli, R Falini, B
Citation: R. Gerli et al., Soluble CD30 in primary Sjogren's syndrome, CLIN EXP RH, 17(3), 1999, pp. 389-390
Risultati: 1-25 | 26-38